PGDX ELIO Trademark

Trademark Overview


On Tuesday, June 6, 2023, a trademark application was filed for PGDX ELIO with the United States Patent and Trademark Office. The USPTO has given the PGDX ELIO trademark a serial number of 98029210. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Saturday, October 4, 2025. This trademark is owned by Personal Genome Diagnostics Inc.. The PGDX ELIO trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific research and development; medical and scientific research, namely, designing, organizing, conducting, monitoring, and managing clinical and non-clinical trials in the field of tumor profiling for others; scientific consulting services for others in the field of conducting clinical and non-clinical trials and studies in the field of tumor profiling; collection, calibration, analysis and reporting of medical and scientific research data in connection with clinical and non-clinical trials and studies in the field of tumor profiling for medical and scientific research purposes; scientific laboratory services; providing temporary use of non-downloadable software through a web-based portal to collect, organize, and report medical information, medical records, and diagnostic testing records; providing an Internet website portal featuring information in the field of medical testing for scientific research purposes, testing for quality control purposes, genetic testing for scientific...
pgdx elio

General Information


Serial Number98029210
Word MarkPGDX ELIO
Filing DateTuesday, June 6, 2023
Status730 - FIRST EXTENSION - GRANTED
Status DateSaturday, October 4, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 18, 2025

Trademark Statements


Goods and ServicesScientific research and development; medical and scientific research, namely, designing, organizing, conducting, monitoring, and managing clinical and non-clinical trials in the field of tumor profiling for others; scientific consulting services for others in the field of conducting clinical and non-clinical trials and studies in the field of tumor profiling; collection, calibration, analysis and reporting of medical and scientific research data in connection with clinical and non-clinical trials and studies in the field of tumor profiling for medical and scientific research purposes; scientific laboratory services; providing temporary use of non-downloadable software through a web-based portal to collect, organize, and report medical information, medical records, and diagnostic testing records; providing an Internet website portal featuring information in the field of medical testing for scientific research purposes, testing for quality control purposes, genetic testing for scientific research purposes, and medical and scientific research data in the field of, disease, medical care, healthcare, pharmaceuticals, medical devices, biochemicals, and biotechnology; providing temporary use of online non- downloadable software for storing, retrieving, accessing, displaying, managing, analyzing, and reviewing information and data in the fields of medical testing, testing for forensic purposes, testing for quality control purposes, genetic testing, clinical and analytical testing, disease, medical care, healthcare, pharmaceuticals, medical devices, biochemicals, and biotechnology.

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, July 10, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePersonal Genome Diagnostics Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBaltimore, MD 21224

Party NamePersonal Genome Diagnostics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBaltimore, MD 21224

Trademark Events


Event DateEvent Description
Friday, June 9, 2023NEW APPLICATION ENTERED
Monday, July 10, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, February 27, 2024ASSIGNED TO EXAMINER
Wednesday, February 28, 2024NON-FINAL ACTION WRITTEN
Wednesday, February 28, 2024NON-FINAL ACTION E-MAILED
Wednesday, February 28, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, May 28, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 28, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, July 2, 2024NON-FINAL ACTION WRITTEN
Tuesday, May 28, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 2, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, December 20, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 2, 2024NON-FINAL ACTION E-MAILED
Tuesday, October 1, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Tuesday, October 1, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Friday, December 20, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, December 20, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, February 12, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, January 24, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 18, 2025PUBLISHED FOR OPPOSITION
Tuesday, February 18, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 15, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Saturday, October 4, 2025TEAS STATEMENT OF USE RECEIVED
Saturday, October 4, 2025SOU EXTENSION 1 FILED
Saturday, October 4, 2025SOU TEAS EXTENSION RECEIVED
Saturday, October 4, 2025SOU EXTENSION 1 GRANTED
Saturday, October 4, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED